ICML 2019 | Lugano, Switzerland

TELLOMAK KOL webcast presentation	1.22 Mo
ICML 2019: TELLOMAK presentation	702.17 Ko
Poster: KIR3DL2 is expressed in peripheral T-cell lymphomas and may be a therapeutic target	521.62 Ko
Poster: KIR3DL2 contributes to delineate the Acute-type and is a therapeutic target in Adult T-cell leukemia/lymphoma	674.14 Ko

Date

mar, 06/18/2019 - 12:16